Lipoprotein(a) and venous thromboembolism: biological plausibility, genetic evidence, and remaining uncertainty
Journal of Thrombosis and Thrombolysis · 03.11.2026
DOI: 10.1007/s11239-026-03429-7 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Thrombosis and Thrombolysis, online erschienen am 03.11.2026. Verfasst von Orly Ran Sapir und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gonda Vascular Center, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. Die Arbeit nennt 17 Literaturangaben.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gonda Vascular Center, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
- Gonda Vascular Center, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. henkin.stanislav@mayo.edu.
Zitieren
APA
Sapir, O. R., & Henkin, S. (2026). Lipoprotein(a) and venous thromboembolism: biological plausibility, genetic evidence, and remaining uncertainty. Journal of Thrombosis and Thrombolysis. https://doi.org/10.1007/s11239-026-03429-7
Vancouver
Sapir OR, Henkin S. Lipoprotein(a) and venous thromboembolism: biological plausibility, genetic evidence, and remaining uncertainty. Journal of Thrombosis and Thrombolysis. 2026. doi:10.1007/s11239-026-03429-7
BibTeX
@article{Sapir2026,
author = {Sapir, Orly Ran and Henkin, Stanislav},
title = {Lipoprotein(a) and venous thromboembolism: biological plausibility, genetic evidence, and remaining uncertainty},
journal = {Journal of Thrombosis and Thrombolysis},
year = {2026},
doi = {10.1007/s11239-026-03429-7}
}
EUVIMED